August - 2012
| Previous Next | Showing Journal 2 of 13 |
Beta-Blocker Continuation After Noncardiac Surgery - A Report From the Surgical Care and Outcomes Assessment ProgramSteve Kwon, MD, MPH; Rachel Thompson, MD; Michael Florence, MD; Ronald Maier, MD; Lisa McIntyre, MD; Terry Rogers, MD; Ellen Farrohki, MD; Mark Whiteford, MD; David R. Flum, MD, MPH; for the Surgical Care and Outcomes Assessment Program (SCOAP) Collaborative Archives of Surgery, 2012, 147(5):467-473 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
August |
Previous Comments
| What was the primary use for the betablocker? was it for IHD,LVF,Arrhythmia or hypertension? How can any "bright spark" lump all such patients together to prove or disprove something????? Terrible waste of time ! | |
| sceptic-17 Sep, 2012 11:36:00 PM | |
| Sceptic indeed. Despite the eclectic nature of the group studies, this is a considerable number of patients, and given the prevalence of the disease groups you mention in our society, they were all likely heavily represented. I'm not suggesting this study is definitive, but it is highly suggestive. Until a highly unlikely RCT is published, it seems important to continue beta blockers wherever possible. | |
| Believer-23 Sep, 2012 09:41:12 AM | |
Comment
This interesting paper, while not a randomised controlled trial, provides some evidence that withholding beta-blocker therapy during the perioperative period is potentially dangerous in those who are on background therapy.